• Shin-Fu Chen, Chih-Chi Su, Chuan-Ching Huang, Paul T Ogink, Hung-Kuan Yen, Olivier Q Groot, and Ming-Hsiao Hu.
• Department of Orthopaedic Surgery, National Taiwan University Hospital, Taiwan; Department of Medical Education, National Taiwan University Hospital, Taiwan. Electronic address: b05401016@ntu.edu.tw.
• J Formos Med Assoc. 2023 Dec 1; 122 (12): 132113301321-1330.

Background/PurposeIdentifying patients at risk of prolonged opioid use after surgery prompts appropriate prescription and personalized treatment plans. The Skeletal Oncology Research Group machine learning algorithm (SORG-MLA) was developed to predict the risk of prolonged opioid use in opioid-naive patients after lumbar spine surgery. However, its utility in a distinct country remains unknown.MethodsA Taiwanese cohort containing 2795 patients who were 20 years or older undergoing primary surgery for lumbar decompression from 2010 to 2018 were used to validate the SORG-MLA. Discrimination (area under receiver operating characteristic curve [AUROC] and area under precision-recall curve [AUPRC]), calibration, overall performance (Brier score), and decision curve analysis were applied.ResultsAmong 2795 patients, the prolonged opioid prescription rate was 5.2%. The validation cohort were older, more inpatient disposition, and more common pharmaceutical history of NSAIDs. Despite the differences, the SORG-MLA provided a good discriminative ability (AUROC of 0.71 and AURPC of 0.36), a good overall performance (Brier score of 0.044 compared to that of 0.039 in the developmental cohort). However, the probability of prolonged opioid prescription tended to be overestimated (calibration intercept of -0.07 and calibration slope of 1.45). Decision curve analysis suggested greater clinical net benefit in a wide range of clinical scenarios.ConclusionThe SORG-MLA retained good discriminative abilities and overall performances in a geologically and medicolegally different region. It was suitable for predicting patients in risk of prolonged postoperative opioid use in Taiwan.Copyright © 2023 Formosan Medical Association. Published by Elsevier B.V. All rights reserved.

13 keywords...

hide…